DR. MARK D. VINCENT

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Aptose Biosciences Inc.

Filing Date Source Excerpt
2019-05-08 Dr. Vincent makes valuable contributions to the Board based on over 25 years of experience as a medical oncologist.
2020-04-24 Dr. Vincent completed his oncology training at the Royal Marsden Hospital on London, England, with a major focus on leukemia/lymphoma.
2021-04-21 Dr. Vincent completed his oncology training at the Royal Marsden Hospital on London, England, with a major focus on leukemia/lymphoma.
2022-04-20 Dr. Vincent makes valuable contributions to the Board based on over 25 years of experience as a medical oncologist.
2023-04-19 Dr. Vincent makes valuable contributions to the Board based on over 25 years of experience as a medical oncologist.
2024-05-15 Dr. Vincent completed his oncology training at the Royal Marsden Hospital in London, England, with a major focus on leukemia/lymphoma.

Data sourced from SEC filings. Last updated: 2025-10-11